Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases

NCT02749734 is registered in ClinicalTrials.gov with Southwest Hospital, China as lead sponsor.

NCT NCT02749734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02749734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases
Lead sponsor
Southwest Hospital, China
Phase
Phase 1/2
Overall status
Unknown status
Start date
May 31, 2015
Completion date
December 31, 2019
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular degeneration, stargardt's macular dystrophy